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A,6 subunit of the neuronal nicotinic receptor, sharing 88% homology with the ratbd subunit, has been cloned from a human neltroblastoma cell 
line. The gene encoding the human p4 subunit isexpresscd inassociation with the a3 gene in neuroblastoma and small-cclt ung carcinoma cell lines. 
Patch-clamp experiments and radioligand binding assays confirm that these neuroendocrine tumor cell lines express functional ncuronal nicotinic 
receptors. We suggest that these rcccptors might play a crucial role in the control of neurotransmitter and hormone secretion from neurosccrctory 
human tumors. 
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1, INTRODUCTION 
Neuronal nicotinic receptors are present in the cen- 
tral mxvcus system (CNS), the peripheral ganglia and 
the adrenal medulla. In these tissues the activation of 
nicotinic receptors causes a localized depolarization of 
the plasma membrane which may also lead to ncuro- 
transmitter release [1,2]. Different gene products (al-a,; 
&&), identified in the rodent and avian systems, par- 
ticipate in the formation of neuronal nicotinic receptors 
[3], which have distinct localization [3] and pharmacol- 
ogical profiles [4]. Very little information is available on 
the molecular properties of human neuronal nicotinic 
receptors. We took advantage of previously choracter- 
ized human cell lines with neuronal properties. Neuto- 
blastoma (NB) is a tumor of the peripheral nervous 
system which is known to release amines and peptide 
hormones into the circulation [S]. Over recent years, in 
vitro-stabilized NB cell lines have proved to be invalua- 
ble tools for the characterization of different types of 
neuronal receptors [6--S]. On the other hand, small-cell 
lung carcinoma (SCC) cell iines derived from epithelial 
lung tumors consist of secretory cells which also express 
a number of neuronal traits [9]. Binding studies have 
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previously shown that SCC cell lines express muscarinic 
cholinergic receptors [ 101, but recent evidence suggests 
that they may also express cholinergic receptors of the 
nicotinic type [ 11 ,123. 
We here report (i) the cloning of the human p4 nico- 
tinic subunit, (ii) the selective xpression of a5 and p4 
nicotinic subunits in human NB and SCC cell lines, and 
(iii) the presence in the same cells of functional nicotinic 
receptors. 
2. MATERIALS AND METHODS 
A @IO EDNA library from the lMR32 human NB cell line (kindly 
provided by H. Soreq) was screened under low stringency conditions 
(hybridization was performed in 43% v/v formamide, 5x SSC, IX 
Denhnrdt’s, 20 mM sodium phosphate butler, pH 6.8.0.18 w/v SDS. 
and 20~g/ml denatured fish sperm DNA at 37°C. Filters were washed 
at a final stringency of 2x SSC, 0. I% SDS at 6G”C.I) USillg probe PC%49 
(kindly provided by S. Heinemann) which encodes the rat pz nicotinic 
subunit [13]. Two positiveoverloppingclones.ilh2l (nt221-1,372)and 
Al122 (nt R81-1,360), were isolated (numbers in parentheses indicate 
the nucleotide residues or the cDNA carried by the clone). DNA 
scqucncing was perfamed in M13mp18 and M13mpl9 using the Sc- 
qucnasc Version 2.0 kit (USB). The two clones were round to contain 
fragments of’ the human fl,, subunit cDNA. Further inrormetion (nt 
I-34G) was obtained by sequencing the PCR amplification products 
from 1MR32 mRNA described below. 
2.2, PCIi ulllp/t~cdotr 
First strand cDNAn were synthesized from poly(A) RNA using the 
first strand cDNA synthesis kit (Stratagene) and the supplied random 
henamcr primer. I/lOth or the first strand reaction was amplified as 
previously described [ 141, The ,9., 5’ sense primer, S’rfl,-S (CAA CAA 
CCT GAT CCG CCC AGC; nt 1’77l97J, was drawn on thepd rat 
seqence [ 153. The primers for human,& (this paper), human aj [lb] and 
p-uctin [II] arc as follows: 3’l@,,-AS (GAA GGG AAA GTA CTT 
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CAC CTC; r-11 3X-346); S’ha,-S (CGA CAT CAA GTA CAA CT; 
nt 558-574); 3’ha,-AS (TAG AGC TTC TCG TCA CC; nr 1,161- 
I, 177); S;B-act-S (CGT GGG GCG CCC CAG GCA CCA GGG; nt 
143-167): 3’p-act-AS (CGG TTG GCC TTG GGG TTC AGG GGG 
G; nt 364-388) 
The ampification products were analyzed by Southern blot using the 
full-length a, and the 2112 I insert as probes, and human @actin was 
detected by ethidium bromide staining. The identity ofp, PCR prod- 
ucts was confirmed by DNA sequencing. 
Electropbysiological experiments on SK-N-BE cells were carried 
out using the standard whole-cell patch-clump technique [I81. Resting 
potential was t?om -50 to -G5 mV. Patch electrode resistance was 3-4 
MR, and 70-758 of the series resistance was compensated for. Mem- 
brane potential was held at -SO mV. Mcmbranc currents were low- 
pass filtered (8 pole Bessel; -3 dB at 1 kHz), digitized (12 bits: 1,024 
points/record) and stored on magnetic discs for off-lint computer 
analysis. 
The external solution contained (in mM): NaCl 135, KCI 5.5, C&I, 
I& MgC& 0.8, HEPES 20, glucose 25. and sucrose 3G.5 (pH 7.3.340 
mOsm). The pipette solution contoined (in mM): KCI 100. KF 50. 
HEPES IO, sucrose 50, and EGTA IO (pH 7.2, 340 mOsm). For 
whole-cell superRation, a continuous flow (I .5 mllmin) or external 
solution was applied kIlTI a I mm diamctcr capillary positioned within 
0.5 mm of the cell. The cells were superllrsed at room temperature 
(RT) with known concentrations ofthc agonist and/or antagonists. To 
improve recovery Tram dcsensilizdtion, cells were washed with cxter- 
nal solution for 4 min between each response. 
[“ti]TPMP+ binding assays were performed as in [20]. with some 
modifications. The dirrerent human call lines were obtained and 
grown as described [ 191. The binding assay was pcrformcd at RT on 
cell homogenates in a bulTer (in mM: N&I IGO, KCI 5, CaCI, 2, 
phenylmethylsulronyI fluoride 0.1, and HEPES IO. pH 7.4) containing 
0.5 mdml BSA, [‘H]TPMP+ 50 nM (46.1 Ci/mnol; DuPont-NEN) 
and different concentrations ofcarbnchol (Cch) (Sigma). Non-specific 
binding was measured in the presence of 5 mM unlabeled TPMP’. 
Alter incubation, tlic samples were resuspended in 3 ml of bulTer 
containing BSA (I mg/ml), and filtered on GFIB filters (Whatman). 
The filters were washed 3 times with 3 ml buffer and radioactivity 
counted. 
3. RESULTS AND DlSCUSSIGN 
3.1. Hutnan p4 rlicotinic receptor suburlit 
Fig. 1 shows an alignment of the amino acid se- 
quences of the human and rat /$ subunits. The deduced 
protein sequence of the human pd subunit (451 amino 
acids) was iacomplete at its N-terminal but revealed the 
canonic primary strucutre of a nicotinic receptor sub- 
unit, which was characterized by four hydrophobic pu- 
tative membrane-spanning re ions and a large cytoplas- 
mic loop. At the amino acid level, the homology be- 
tween human and rat subunits was 88%. The most di- 
vergent region was represented by the cytoplasmic do- 
main (77% homology), where the human subunit also 
had a deletion of four amino acids. 
3.2. kpression of ha3 and h/3., in nerrrortal und non- 
rwtrronul ceN titles 
It is known that rat and chick a, and /X, subunits are 
human Pr, . . .TSSSPLISIK~LS~LISVHBR 24 
llllllllI I Ill llllllll 
rot P4 RLAN~KLMWLLNKTRYNNLIRPAT~~L~E~RLELSLSQLXSVN~R DO 
0 
human p4 DE~~TfHVLPLKPEH~YRL~SSRYE~ILRIPN~NA 74 
llllllllllI III1 IIIIIIIIIIIII IIIIIIIIlll 
rat De EPTMTTSIWLL(QSWTDYRLhWIISSCIR~NILRlPAnRYLILPDIVLIHNA 100 
0 t 0. 
DtTYEVSVYTNLI’.‘XSMG?iVLHLPPAIYKSACK~EVKYFPFDQQ2?ZTLKF 124 
IIllllllIll Illllll IIlllIIlllllllll llllllll II 
DGTYEVSWT~I~SUGS~OWLPPAt7KShncIeVKliFPFDPQBEAVKF 150 
ASWTYDHTEfDMVTMTPThSMDDFTPSGeWDIVALPGRR~NPQDPS~ 174 
III1 IIllllllI III llllllllIIlllllllIIIIIIIIllllI 
RSHTSDHTNI~MVLKSCTA:MDDFTPSGEnDIVA~~~NPQDP5~ 200 
YTYDFIIKRKPLFYTINLIIP~rPLUILYFILPBOCGE~KISYL 224 
IIIIlllllIIIII llllllllI I lIIIfIIIIIIIII!IlIIIIII 
VTYC?fIKRKPLPII~SECCEKKT.lUS%la 2bO 
IALTFFLLLISWIVPPTSLDVPL~GKYX&FTl4VLVTFSIV-CSYCVLNVlIH 274 
IllllllllIIIIIIIIIII lllllll lllllllIIIII IlllllII 
mTSLDfPLIGK7pH 200 
RSPCTIITMhPrNKRCFLILFTFLF~~GPDSSPARE 224 
IlIIlIIll III IIIIIIIIIIIIIIII I I II 
RSPSTHI~SSWVKECFLHKLPTFLF~~RPCLEVSLVRVPHPSOLHLATAD 210 
ATATS----‘IiPSNFYGNSMYFV?iPASARSNSPAGSTPVAXPRDFWLRSS 170 
I I I IIIII II IIIIIII Ilil I III IllI 
TAATSALCPTSPSNLYOSSMYFVHPVPAAPKSAVSSHTAGLPRDRRLRSS 400 
humn b4 GRFIIODVPEAIECVSF~AQHP?nlDDEDQS~DWKWh 420 
Illi I llIIIIIIIIIII II III1 III1 /lIIIIIlllIII 
rat P4 CRFREDLQ~:AtEGVSFIAPHLESDDRUQIVIEDHKWII*IWDRISL)IWW 450 
hurcx, p4 ~~CVLGTVGLFLPPLFQTHAUECPYAAQP3 stop 451 
III III IIIllIIlI II I 
rat p4 m t ’ QIHAPSKDS nrop 475 
Fig. I. Alignment of human and rat /?, subunit amino acid sequences. 
The one-letter amino acid notation is used. Putative transmembranc 
regions are underlined. Asterisks (*) indicate tbc cysteines conserved 
in all ligand-gatcd ion channels. Circles (‘) indicate glycosylation sites. 
highly expressed in the peripheral nervous system and 
that , when expressed in Xenopus occytes, they yield 
functional nicotinic receptors with a ganglionic phar- 
macology [21]. IMR32 and SK-N-BE human NB cells 
have already been shown to express ali [ 161 and a5 nico- 
tinic subunits, but not ccl [123. By means of Northern 
blot analysis (Fig. 2), we now show that both IMR32 
and SK-N-BE express asingle b., transcript of about 3.1 
kb. Given that NB originates from ganglionic periph- 
eral neurons, this findings in human cells is in line with 
previous reports on rat. 
Furthermore, PCR amplification (Fig. 3) showed that 
the a3 and pA nicotinic subunits were expressed in two 
different SCC cell lines (NCW-I-69; NCI-N-592 not 
shown) although they were not expressed in either a 
lung non-SCC (A549) or a rhabdomyosarcoma (TE671) 
ceii iine. Thus the expression of the c+ and & nicotinic 
subunits is not confined to the nervous ystem but also 
appears in cells of the neuroendocrine type. 
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Fig. 2. Northern blot analysis of RNA from human neuroblastoma 
cells. Analysis of poly(A) R.NA from SK-N-BE and fMR32 cells (LO 
mg each) was performed under high stringency conditions (final wash 
stringency: 0. lx SCC, 0.1% SDS, SOOC) using the Ah21 clone insert as 
probe. Autoradiography was at -7OOC for 2 days, 3.1 indicates the 
length of the transcript in lib. 
NB C&Y 
Superfusion with 1 mM acetylcholine (Ach) resulted 
in transient inward currents in most of the SK-N-BE (n 
= 13 cells tested) (Fig. 4) with peak amplitudes ranging 
from 0.2%3,50 nA. The Ach-induced inward current 
was completely and reversibly blocked by both 10 ~LM 
d-tubocurarine (Fig, 4a) and I yM TPMP’ (Fig. 4b), 
thus confirming the nicotinic nature of the Ach-induced 
currents. SK-N-BE and lMR32 are the first human 
neuronal cell lines of peripheral origin found to express 
the a3 and/I4 nicotinic subunits which might be involved 
in the formation of the functional nicotinic receptors 
here described, However, we cannot exclude the possi- 
bility that other a and /3 nicotinic subunits may be ex- 
pressed in these cells and contribute towards the forma- 
tion of different functional nicotinic channels. Several 
attempts were made to patch-clamp SCC cells, but the 
recordings were insufficiently stable to permit the char- 
acterization of the acetylcholine-induced currents. We 
therefore used the following approach to obtain indirect 
proof of the presence of functional nicotinic receptors, 
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Fig, 3. PCR nnalysis of tq and fi,, RlUA in different human cell lines. 
Human os and @, amplification prwducts from SK-N-RR, NWH-69, 
A 549 and TE 671 cells were analyzed by Southern blot with specific 
cDNA probes. The PCR products of ha, and the t&were only present 
in SK-N-BE and NCI-H-69 cells, The same results wcrc obtained in 
NCI-N-592 cells (not shown). The @actin control (B-act) was detect- 
able by ethidium bromide staining in all of the lanes. 
3.4. [3JI]TPMP’ birtdhtg lo humutt NB attd SCC cc/l 
hex 
TPMP” binding to the nicotinic receptor is allosteri- 
tally modulated by cholinergic effecters [20]. This chan- 
nel blocker binds to residues located inside the pore of 
the channel, which become available after receptor acti- 
vation, The blocking effects of TPMP’ on the muscular 
nicotinic receptor have been previously characterized 
[22j, and we have shown here that it also blocks neu- 
ronal nicotiaic currents in SK-N-BE cells (see above). 
As expected [3H]TPMP+ binding in SK-N-BE cells was 
positively modulated, in a dose-dependent manner, by 
Cch (Fig. 5B>. The specific binding of i;HjT’PMPi was 
maximally stimu!ated by lo-” M Cch. Cch also stimu- 
lated the specific binding of [jHjTfMP+ in NCI-H-69 
(Fig. SC) and NCI-N-592 (not shown) SCC cell lines 
which, like NB, express the cc3 and ,& nicotinic receptor 
subunits. On the other hand, in the lung non-SCC cell 
line (A549), which does not express either a3 of /?., sub- 
units, the binding of [‘H]TPMP’ was not stimulated by 
Cch (Fig. SD). As a control, an allosteric modulation 
of [3H]TPMP+ binding was also shown in TE671 cells, 
which are known to express muscle-type nicotinic recep- 
tors and the a, nicotinic subunit (Fig. SA). 
The expression of functional neuronal nicotinic re- 
ceptors in SCC cell lines is a novel and intriguing tind- 
ing. We suggest hat these receptors hould be consid- 
ered as new members of the growing list of neuronal 
markers selectively expressed by this type of lung 
tumor. Neuronal nicotinic receptors are known to medi- 
ate the secretagogue effects of endogenous acetylcholine 
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Pig. 4. Electrophysizlogical recordings in SK-N-BE cells. (a) inward control currents induced by 1 mM Ach (left) are completely blocked after 
3 min of superfusion with lO,uM d-tubocurarinc ( enter). Recovery from tile block is observed al’tc-r 4 min ofwashin8with control external medium 
(right). (b) Inward control currents induced by I mM Ach (left) are completely blocked after 7 min ofsuperfusion with 1 NM TPMP’ {center). 
Recovery from the block is observed after 13 min of washing with control external medium (ri8ht). Superfusion periods are indicated by bars. 
and exogenous nicotine in a number of tissues, and we 
have also demonstrated the secretagogue effects of nic- 
otine on SCC cell lines (E. Sher, manuscript in prepara- 




Fig. 5. Dose-response curves of the cB’ects of Cch on [‘H]TPMP+ 
binding. Cch-induced increases in[‘H]TDMP+ bindinp were cvzluatcd 
in TE 671 (A). SK-N-BE (9, NCi-Ii-69 (C; and A549 CD; cd!s. 
Specific [‘HJTPMP’ binding in the absence of carbachol was consid- 
cred as 100%. Yalues represent the averuge of 3-8 experiments, each 
performed in triplicate. 
previously been described [i 1,23,24], but no informa- 
tion is available on the molecular nature of nicotine 
targets. The present characterization of neuronal nico- 
tinic receptors in SSC, a subtype of human lung cancer, 
the association of which cigarette smoking is well dem- 
onstrated [25], offers new insights into the possible 
mechanisms by which nicotine might affect tumor cell 
physiology and proliferation. 
Ac~/to~lll~~~r~,z~~~~,~~ We thank N. BorSesc and C. Gotti for their dis- 
cussions and extensive comments on the manuscript; J. Mahsco for 
oiigonucleotidc synth&s; S. Heinemann for the sift of the/& cDNA 
probe; H. Soreq for the lMR32 EDNA library; G. Melino, G. 
Gaudino. 5. Tzartos and A. Ciomei for cell lines; and K. Smart and 
I. RutToni for manuscript revision. The paper was supported by CNR 
tar8eted projects ‘Prevcnrion and Control of Disease Factors’ and 
‘AginS’. 
REFERENCES 
[I] Wannacott. S., Irons, J., Lunt. 0.0.. Rapier. CM. and Al- 
buquerque. E.X. (1988) in: Nicotinic Acctylcholine Receptors in 
the Nervous System (Clementi, F., Got& C. and Shcr. E. eds.) 
NATO ASI Series H: Cell Biology vol. 25. pp. 41-60. Springer* 
Vcrlag, Berlin. 
[2] Roll, L.W. and Perlman, R.L. (1983) Neuroscicnoc 10,979-985. 
[31 Dencris. ES.. Connolly, J., Rogers. S.W. andDuvoisin. R.(i991) 
Trends Eharmacol. Sri. 12. 34-40. 
[4] Luetjc, C.W. and Patrick, 3. (1991) .I. Neurosci. it, 537-845. 
[S] H&o, R.J.. SeeSer, RX., Yu, AL. and O’Connor, D.T. (1990) 
J. Clin. Invest. 85, 1555-l 559. 
{6] Clementi, F.. Cabrini. D.. Gotti, C. and Sher. E. (1986) 1. NCUFO- 
them. 47, 29 l-297. 
[7] Gotti. C., Esparis 08ando. A. and Clcmcnti, F. (1989) Ncuro- 
ssicnee 32, 759-767. 
69 
Volume 312, number I FEN LETTERS November 1992 
[S] Abbracchio. M.P.. Cattabcni, F., Clementi, F. and Sher, A. 
(1989) Neuroscience 30. 519-825. 
[l7] Ponte, P., Ng:, S-Y,, Engee), J., Gunning, P. and Kedes, L. (1984) 
Nucleic Acid Res. 12. 1687-1696. 
[9] Teeli& M.E. and Carney, D.N. (1985) in: Biology of Lung 
Cancer: Diagnosis and Treatment Biocbcmical Markers of Lung 
Cancer (Rosen, ST., Mulshine. J., Cutitta. F. and Abram% P.C. 
cds.) pp. 43-58, Marccl Dckkcr, New York. 
[IO] Cunningham, J., Lennon, Y., Lamben, E. and Scheithauer, B. 
[18] Hamill, OP., Marty,.A., Nchcr, E., Sakmann, B. and SiBworth, 
F.J. (1981) Pflllgcrs Arch. 391, 85-100. 
[I91 Shcr, E., Pandiella, A. and Clementi, F. (1990) Cancer Res. 5, 
3892-3896. 
WI 
(1985) 1. Neurochem. 45. 159-167. 
Lauffer, L, and Hucho, F. (1982) Proc. Natl. Acad. Sci. USA 79, 
24062409. 
[I I] Maneckjee, R. and Minna, J.D. (1990) Proc. Natl. Acad. Sci. 
USA 87, 3294-3298. 
[2ll 
[I 21 Chini, B.. Clementi, F.. Hukovic. N. and Sher. E. (1992) Proc. 
Natl. Acad. Sci. USA S9, 1572-1576. 
[I31 Dcneris. ES.. Connolly, J., Boulter, J., Wada, E., Wada, K., 
Swanson, L.W.. Patrick, J. and Heinemann, S. (1988) Neuron I. 
45-54. 
1141 Frohman. M.A., Dush, MR. and Martin, G.R. (1988) Proc. 
Natl. Acad. Sci. USA 85, 5995-9002. 
[15] Duvoisin, R.M., Deneris, ES., Patrick, J. and Hcinemann, S. 
(1989) Neuron 3,487-496. 
[16] Fornasari, D., Chini, B., Tarroni, P. and Clementi, F. (1990) 
Neurosci. Lett. I I I. 351-356. 
Couturier, S., Erkmun, L., Valera, S., Rungger, D., Bertrand, S., 
Boulter. J.. Ballivet. M. and Bertrand, D. (1990) J. Biol. Chcm. 
2G5, 17560-l 7567. 
Spivak, C.E. and Albuquerque, E.X. (1984) Mol. Pharmacol. 27, 
246-255. 
Shuller, H.M. (1989) Biochem. Pharmacol. 38, 34393442. 
Tominaua. K.. Kinoshita. Y.. Hato. F.. Masuda. A. and 
Matsuy&a, M’. (1989) Celi. Mol. Biol: 35’679-686. . 
lannuzzi, MC. and Scoggin, C.H. (1986) Am. Rev. Rasp. Dis. 
134, 593-608. 
